HDAC9 and cancer: Indeed, the etiologies and complications which contribute to the remaining primary causes of death (heart disease, cancer, lower respiratory disease, stroke, Alzheimer's disease, diabetes, influenza and pneumonia, and kidney disease) are also inflammatory-mediated, and so discussion of HDAC inhibitors and their therapeutic, anti-inflammatory capacities is warranted.